{
    "title": "Omeros terminates development of kidney disease therapy after study failure",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12635743/Omeros-terminate-kidney-disease-trial-therapy-fails-late-stage-study.html",
    "date": "2023-10-16",
    "keywords": [
        "therapy",
        "company",
        "roy",
        "disease",
        "study",
        "protein",
        "igan",
        "blood",
        "placebo",
        "cash",
        "corp",
        "monday",
        "development",
        "type",
        "kidney",
        "latestage",
        "failure",
        "research",
        "omeros",
        "low",
        "half",
        "market",
        "capitalization",
        "analysis",
        "improvement",
        "symptom",
        "narsoplimab",
        "reduction",
        "group",
        "reaction",
        "data",
        "point",
        "gregory",
        "demopulos",
        "call",
        "trial",
        "marketing",
        "application",
        "health",
        "regulator",
        "approval",
        "decision",
        "drug",
        "developer",
        "end",
        "quarter",
        "commercialization",
        "treatment",
        "covid19",
        "microangiopathy",
        "complication",
        "bone",
        "marrow",
        "transplant",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}